Rouan Sarah Kathryn 4
4 · Viking Therapeutics, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Rouan Sarah Kathryn
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-01-02+32,000→ 32,000 totalExercise: $18.28From: 2025-01-02Exp: 2034-01-02→ Common Stock (32,000 underlying)